Market Tracker

07/28 4:31am ET

NewLink Genetics Corp (NASDAQ:NLNK)

7.00
Delayed Data
As of Jul 27
 -0.35 / -4.76%
Today’s Change
5.90
Today|||52-Week Range
25.17
-31.91%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close7.35
Today’s open7.37
Day’s range6.97 - 7.40
Volume566,348
Average volume (3 months)865,338
Market cap$214.8M
Dividend yield--
Data as of 07/27/2017

Growth & Valuation

Earnings growth (last year)-108.51%
Earnings growth (this year)+3.06%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.78%
P/E ratioNM
Price/Sales8.33
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...-0.67-7.55%
ALBOAlbireo Pharma Inc-0.47-1.90%
GEMPGemphire Therapeutic...+0.72+3.69%
URGNUrogen Pharma Ltd-0.40-2.13%
Data as of 07/27/2017

Financials

Last reporting dateJuly 28, 2017
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$35.8M
Annual profit (last year)-$85.2M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts